Pharmacokinetic Modelling of Levosimendan in Adults

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

July 30, 2027

Study Completion Date

August 31, 2027

Conditions
Cardiogenic Shock
Interventions
OTHER

Adult patients in cardiogenic shock

evaluate the elimination clearance of levosimendan (LVSMD) in the group without extracorporeal membrane oxygenation (ECMO) and in the group with ECMO.

Trial Locations (3)

59037

Anesthesia Clinic - Resuscitation, University Hospital of Lile, Lille

76031

Anesthesia-Resuscitation Department, University Rouen Hospital, Rouen

80054

Cardio-Thoracic-Vascular Resuscitation Department, university Hospital of Amiens, Amiens

All Listed Sponsors
collaborator

University Hospital, Lille

OTHER

collaborator

Amiens University Hospital, France

UNKNOWN

lead

University Hospital, Rouen

OTHER

NCT06993584 - Pharmacokinetic Modelling of Levosimendan in Adults | Biotech Hunter | Biotech Hunter